Insiders Alkermes plc

Equities

Real-time Estimate Cboe BZX Other stock markets 17:23:21 26/06/2024 BST			5-day change	1st Jan Change
24.25 ^USD	+0.29%		-3.11%	-12.51%

06-17	TD Cowen Initiates Alkermes at Buy With $34 Price Target	MT
06-11	Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM

Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing	03-19	MT
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	03-07	CI
Alkermes plc Announces Executive Changes	02-05	CI
Alkermes plc Announces Changes to its Board	12-08	CI
Biogen shareholders back Susan Langer as director	26/06/23	RE
ISS recommends one of Sarissa's three nominees for Alkermes board	20/06/23	RE
ISS backs election of Langer to replace former Biogen director Denner	15/06/23	RE
Sarissa's Denner quits Biogen board as firm seeks seats at Alkermes	14/06/23	RE
Sarissa's Denner quits Biogen board as firm seeks seats at Alkermes	13/06/23	RE
Alkermes Names Caroline Loew Chief Executive Officer Designate of Planned Oncology Company	02/06/23	MT
Insider Sell: Alkermes	10/05/23	MT
Alkermes plc Receives a Notice from Sarissa Capital	07/02/23	CI
Insider Buy: Alkermes	16/11/22	MT
Insider Sell: Alkermes	21/06/22	MT
Alkermes plc Announces Management Changes	26/05/22	CI
Insider Sell: Alkermes	20/05/22	MT
Insider Sell: Alkermes	03/05/22	MT
Insider Sell: Alkermes	03/05/22	MT
Insider Sell: Alkermes	19/04/22	MT
Alkermes plc Announces Appointment of Cato T. Laurencin to Its Board of Directors	19/11/21	CI

No results for this search